Study guide

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol

Key Takeaways Explain This Topic AI

The single-breath DLCO test (DLCO-SB or Modified Krogh technique) measures the rate of carbon monoxide transfer across the alveolar-capillary membrane using a test gas mixture of 0.3% CO, 10% tracer gas (Helium or Methane), 21% O2, and N2 balance.

Inspired volume must be at least 90% of the largest prior vital capacity; 85 to 90% is acceptable only when the alveolar volume agrees within 200 mL or 5% of the largest acceptable VA.

Breath-hold time must be maintained for 8 to 12 seconds, calculated according to the ATS/ERS standard Jones-Meade method (measured from 30% of inspiratory time to the midpoint of alveolar sample collection).

Gas collection uses a 0.75 to 1.0 L dead-space washout (0.5 L when VC is below 2.0 L) followed by a 0.5 to 1.0 L alveolar sample, with collection completed within 4 seconds of the start of exhalation.

A minimum rest interval of 4 minutes is required between acceptable maneuvers to ensure complete washout of inspired gases and clearance of CO from pulmonary capillary blood.

Last updated: August 2026

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol

Determining the diffusing capacity of the lung for carbon monoxide ( D L C O DL_{CO} D L CO ​ ) —also referred to internationally as the transfer factor ( T L C O TL_{CO} T L CO ​ )—is a cornerstone diagnostic modality in pulmonary function testing. While spirometry and lung volume determinations quantify the mechanical and volumetric properties of the lungs, D L C O DL_{CO} D L CO ​ evaluates the functional capability of the alveolar-capillary membrane to transfer gas from the alveoli into the pulmonary capillary blood stream.

Carbon monoxide is the ideal test gas for assessing diffusing capacity because its uptake across the alveolar-capillary membrane is diffusion-limited rather than perfusion-limited. Because carbon monoxide binds to hemoglobin with an affinity approximately 210 times greater than that of oxygen, the partial pressure of free dissolved CO in pulmonary capillary plasma remains virtually zero during a brief test maneuver. Consequently, the rate of CO uptake across the alveolar-capillary membrane is directly proportional to the surface area available for gas exchange, the physical diffusion properties of the membrane barrier, and the total mass of functional hemoglobin in pulmonary capillary blood.

Test Gas Composition

Standard single-breath D L C O DL_{CO} D L CO ​ testing ( D L C O -SB DL_{CO}\text{-SB} D L CO ​ -SB , historically termed the modified Krogh technique) utilizes a precisely certified gas mixture containing four primary components:

Carbon Monoxide ( 0.3 % CO 0.3\% \text{ CO} 0.3% CO or 3 , 000 ppm 3,000 \text{ ppm} 3 , 000 ppm ): Serves as the primary indicator gas to measure alveolar-capillary transfer.

Inert Tracer Gas ( 10 % Helium [He] 10\% \text{ Helium [He]} 10% Helium [He] or 0.3 % Methane [CH 4 ] 0.3\% \text{ Methane [CH}_4\text{]} 0.3% Methane [CH 4 ​ ] ): An insoluble, non-absorbable gas used to calculate the alveolar volume ( V A V_A V A ​ ) at full inspiration via single-breath gas dilution and to determine the initial alveolar CO concentration ( F A , C O , 0 F_{A,CO,0} F A , CO , 0 ​ ) prior to diffusion.

Oxygen ( 21 % O 2 21\% \text{ O}_2 21% O 2 ​ ): Maintained at standard ambient room-air concentration to ensure normoxia and prevent competitive displacement of CO at hemoglobin binding sites. (Special hyperoxic mixtures using 98 % O 2 98\% \text{ O}_2 98% O 2 ​ are utilized only when separating membrane diffusing capacity D M D_M D M ​ from pulmonary capillary blood volume V c V_c V c ​ ).

Nitrogen ( N 2 N_2 N 2 ​ ) Balance: Forms the remaining balance of the gas mixture.

Patient Preparation and Pre-Test Guidelines

To prevent artifactual alterations in D L C O DL_{CO} D L CO ​ measurements, pulmonary technologists must enforce strict pre-test patient preparation protocols prior to testing:

Abstinence from Smoking and Vaping: The patient must abstain from smoking cigarettes, cigars, pipes, or electronic vaping devices for at least 4 hours (ideally 12 to 24 hours) prior to testing. Smoking elevates blood carboxyhemoglobin ( C O H b COHb CO H b ) levels, creating a "back-pressure" effect that reduces the partial pressure gradient for CO uptake and artificially lowers measured D L C O DL_{CO} D L CO ​ .

Discontinuation of Supplemental Oxygen: If clinically safe, supplemental oxygen therapy must be discontinued for at least 15 to 20 minutes prior to D L C O DL_{CO} D L CO ​ testing. Breathing elevated F I , O 2 F_{I,O2} F I , O 2 ​ increases alveolar oxygen partial pressure ( P A , O 2 P_{A,O2} P A , O 2 ​ ), which competitively inhibits CO binding to hemoglobin and falsely depresses measured D L C O DL_{CO} D L CO ​ . If a patient cannot tolerate O 2 O_2 O 2 ​ withdrawal, the supplemental F I , O 2 F_{I,O2} F I , O 2 ​ must be recorded, and the testing report must note the hyperoxic conditions.

Avoidance of Heavy Exercise: Strenuous physical exertion must be avoided for at least 2 hours prior to the test. Intense exercise increases cardiac output and pulmonary capillary blood volume ( V c V_c V c ​ ), which transiently elevates D L C O DL_{CO} D L CO ​ .

Medication Withholding: Routine bronchodilators do not significantly alter D L C O DL_{CO} D L CO ​ in non-asthmatic patients, but standard pre-test bronchodilator withholding schedules are often maintained if spirometry is performed during the same session.

Step-by-Step Clinical Testing Protocol

Executing an acceptable single-breath D L C O DL_{CO} D L CO ​ maneuver requires strict adherence to standardized sequence and timing:

Baseline Phase and Positioning: The patient sits comfortably upright in an ergonomic testing chair with a nose clip applied. The patient breathes tidal room air through a low-resistance two-way valve assembly until a stable end-expiratory tidal level (FRC) is established.

Exhalation to Residual Volume: Upon prompt, the patient performs an unforced exhalation down to Residual Volume (RV) . This exhalation should be complete, smooth, and accomplished within ≤ 6.0 seconds \le 6.0\text{ seconds} ≤ 6.0 seconds (or ≤ 12.0 seconds \le 12.0\text{ seconds} ≤ 12.0 seconds in patients with severe airflow obstruction).

Rapid Maximal Inspiration ( V I V_I V I ​ ): At RV, the valve rapidly switches the patient to the D L C O DL_{CO} D L CO ​ test gas reservoir. The patient inspires maximally to Total Lung Capacity (TLC) as rapidly as possible.

Volume Requirement (the 90%/85% rule): The inspired volume ( V I V_I V I ​ ) should be ≥ 90 % \ge 90\% ≥ 90% of the largest previously recorded Vital Capacity obtained in the same session. A V I V_I V I ​ between 85% and 90% is still acceptable only if the resulting alveolar volume ( V A V_A V A ​ ) is within 200 mL or 5% of the largest V A V_A V A ​ from another acceptable maneuver. Below 85%, the maneuver is rejected. (Older references quote a flat " ≥ 85 % \ge 85\% ≥ 85% " rule; the 2017 ERS/ATS DLCO standard tightened it to 90% with the 85% conditional exception.)

Time Requirement: At least 85% of V I V_I V I ​ must be inhaled within 4.0 seconds (target < 2.5 < 2.5 < 2.5 seconds in healthy adults). Slow inspiration invalidates the maneuver because meaningful CO uptake occurs before the formal breath-hold begins.

Breath-Hold Period at TLC: Once TLC is reached, the patient holds their breath at full inspiration for 8 to 12 seconds (target 10 ± 0.5 seconds 10 \pm 0.5\text{ seconds} 10 ± 0.5 seconds ).

Physiological Caution: The patient must remain relaxed during the breath-hold. They must avoid performing a Valsalva maneuver (forced expiration against a closed glottis), which increases intrathoracic pressure, squeezes blood out of the pulmonary capillaries, and falsely decreases D L C O DL_{CO} D L CO ​ . Conversely, a Müller maneuver (forced inspiration against a closed glottis) generates negative intrathoracic pressure, engorges pulmonary capillaries, and falsely increases D L C O DL_{CO} D L CO ​ .

Exhalation and Sample Collection: After the breath-hold, the patient exhales smoothly and without hesitation.

Washout Volume Phase: The initial 0.75 L to 1.0 L 0.75\text{ L to } 1.0\text{ L} 0.75 L to 1.0 L of exhaled gas is diverted and discarded into a washout container (or cleared past the gas sampling port). This volume represents anatomical and equipment dead space containing gas that did not participate in alveolar exchange.

Special Exception: If the patient's Vital Capacity is < 2.0 Liters < 2.0\text{ Liters} < 2.0 Liters , the required washout volume is reduced to 0.50 Liters 0.50\text{ Liters} 0.50 Liters to ensure adequate gas remains for the alveolar sample.

Alveolar Sample Collection: Immediately following dead-space washout, an alveolar sample of 0.50 L to 1.0 L 0.50\text{ L to } 1.0\text{ L} 0.50 L to 1.0 L is collected into a sampling bag or analyzed continuously via rapid-response multi-gas analyzers. Per the 2017 ERS/ATS standard, sample collection must be completed within 4 seconds of the start of exhalation , which in practice means the whole washout-plus-sample sequence has to be executed briskly.

Protocol Phase Standard Parameter / Specification ATS/ERS Acceptability Rule / Clinical Impact

Test Gas Mixture 0.3 % CO , 10 % He (or C H 4 ) , 21 % O 2 , N 2 bal 0.3\% \text{ CO}, 10\% \text{ He (or } CH_4), 21\% \text{ O}_2, N_2 \text{ bal} 0.3% CO , 10% He (or C H 4 ​ ) , 21% O 2 ​ , N 2 ​ bal Standardized diffusion and tracer concentration

Pre-Test Prep No smoking ≥ 4 hours \ge 4\text{ hours} ≥ 4 hours ; No supplemental O 2 ≥ 15 − 20 min O_2 \ge 15-20\text{ min} O 2 ​ ≥ 15 − 20 min Prevents C O H b COHb CO H b back-pressure and hyperoxic O 2 O_2 O 2 ​ competition

Inspiratory Volume ( V I V_I V I ​ ) ≥ 90 % \ge 90\% ≥ 90% of largest prior V C VC V C (85-90% acceptable only if V A V_A V A ​ agrees within 200 mL or 5%) Ensures maximum recruitment of alveolar-capillary bed

Inspiratory Duration ≤ 4.0 seconds \le 4.0\text{ seconds} ≤ 4.0 seconds ( ≥ 85 % V I \ge 85\% V_I ≥ 85% V I ​ achieved in < 4.0 s < 4.0\text{ s} < 4.0 s ) Prevents premature CO uptake during inspiratory phase

Breath-Hold Duration 8.0 to 12.0 seconds 8.0\text{ to } 12.0\text{ seconds} 8.0 to 12.0 seconds (Target: 10.0 ± 0.5 s 10.0 \pm 0.5\text{ s} 10.0 ± 0.5 s ) Standardized contact time for CO uptake across membrane

Breath-Hold Technique Relaxed at TLC (No Valsalva or Müller) Maintains stable pulmonary capillary blood volume ( V c V_c V c ​ )

Washout Volume 0.75 to 1.0 L 0.75\text{ to } 1.0\text{ L} 0.75 to 1.0 L (reduced to 0.50 L 0.50\text{ L} 0.50 L if V C < 2.0 L VC < 2.0\text{ L} V C < 2.0 L ) Clears anatomical dead space ( V D V_D V D ​ )

Sample Collection Volume 0.50 to 1.0 L 0.50\text{ to } 1.0\text{ L} 0.50 to 1.0 L ; collection completed within 4 s of the start of exhalation Captures representative alveolar gas sample

Inter-Test Rest Period Minimum 4 minutes 4\text{ minutes} 4 minutes room-air breathing Clears tracer gas and CO from alveolar spaces and blood

Breath-Hold Timing Methods: The Jones-Meade Standard

Accurate calculation of D L C O DL_{CO} D L CO ​ depends critically on precisely defining the breath-hold time ( t t t ). Three historical methods have been used to measure breath-hold duration, but current ATS/ERS guidelines explicitly specify the Jones-Meade Method as the universal gold standard:

Jones-Meade Method (ATS/ERS Standard): Breath-hold time begins at 30 % (0.30) 30\% \text{ (0.30)} 30% (0.30) of the inspiratory time ( t I t_I t I ​ ) and ends at the midpoint of the alveolar sample collection time ( t S t_S t S ​ ) . By incorporating 30 % 30\% 30% of inspiration and half of sample collection, the Jones-Meade formula accounts for the small amounts of CO diffusion occurring during gas entry and exhalation. t Jones-Meade = ( t inspiration − 0.30 × t I ) + t hold + ( 0.50 × t S ) t_{\text{Jones-Meade}} = (t_{\text{inspiration}} - 0.30 \times t_I) + t_{\text{hold}} + (0.50 \times t_S) t Jones-Meade ​ = ( t inspiration ​ − 0.30 × t I ​ ) + t hold ​ + ( 0.50 × t S ​ )

Ogilvie Method (Historical): Measured breath-hold time from the beginning of inspiration to the beginning of alveolar sample collection . This method overestimates total contact time and yields slightly lower D L C O DL_{CO} D L CO ​ values.

Epidemiology Standardization Project (ESP / Ferris) Method: Measured time from the end of inspiration (completion of V I V_I V I ​ ) to the beginning of alveolar sample collection . This method underestimates total contact time and yields higher D L C O DL_{CO} D L CO ​ values.

Repeatability and Quality Assurance Criteria

To achieve clinical acceptability and repeatability during a testing session:

Number of Trials: At least two acceptable maneuvers must be obtained.

Repeatability Standard: The two acceptable D L C O DL_{CO} D L CO ​ values must agree within 2.0 mL CO/min/mmHg 2.0\text{ mL CO/min/mmHg} 2.0 mL CO/min/mmHg ( 0.67 mmol/min/kPa 0.67\text{ mmol/min/kPa} 0.67 mmol/min/kPa ) of each other. This is an absolute criterion only — the 2017 ERS/ATS standard dropped the older "3 mL/min/mmHg or 10%" alternative. The stale percentage rule wrongly passes pairs such as 40.0 and 37.0 mL/min/mmHg, which differ by 3.0 and therefore fail the current standard.

Maximum Trial Limit: No more than 5 maneuvers should be performed in a single testing session. Performing excess trials causes cumulative accumulation of carbon monoxide in pulmonary capillary blood (increasing C O H b COHb CO H b levels), which falsely depresses subsequent D L C O DL_{CO} D L CO ​ values.

Inter-Test Rest Interval: A mandatory delay of at least 4 minutes breathing room air must separate successive D L C O DL_{CO} D L CO ​ trials. This delay allows complete washout of inspired tracer gas from the lungs and clears transiently elevated alveolar CO concentrations. In patients with severe obstructive airway disease or slow-ventilating compartments, this interval should be extended to 6 to 10 minutes.